drug pricesとは 意味・読み方・使い方

Acceleration of approval reviews The problems with the drug pricing system in terms of promoting and expanding the drug industry have been referred to. These include the impediment to healthy competition of a system in which prices fall continuously under the drug pricing criteria and special case reductions of original drugs etc. that are independent of market prices.例文帳に追加

薬価制度については、医薬品産業の振興及び発展という観点から、薬価基準の下では継続的に価格が下がり続ける、先発医薬品の特例引下げなどの市場価格に依らない仕組みは健全な競争を阻害する等の指摘がされている。 - 厚生労働省

A Drug Price Stability Fund, having a legal entity and reporting to the Minister of Health and Population, shall be established to maintain stability in the prices of drugs - other than export drugs - with a view to achieve health development and to guarantee that drug prices are not affected by incidental changes.発音を聞く 例文帳に追加

健康改善及び偶発的変化が医薬品価格に影響しないことを保証することを目的として、輸出医薬品以外の医薬品の価格安定維持のため、法人格を持ち保健国民大臣に報告をする医薬品価格安定基金が設立されるものとする。 - 特許庁

From this perspective, given the situation under the present drug pricing system where, even during the patent life, drug prices are structured to fall continuously and moreover are used for comparison in the calculation of drug prices, even the corrected prices of new drugs are likely to fall below the level in the major European countries and the US, leading to more increases rather than reductions on the application of the foreign price adjustment. In respect of drugs which thus are expected to be more highly priced abroad than in Japan, it has been pointed out that launch overseas gives more favorable drug pricing and that the pricing system has become unfavorable to domestic lead-off development.例文帳に追加

この観点からみると、現在の薬価制度の下では、特許期間中でも薬価が継続的に下落し得る構造になっており、また、そのような価格を比較対照として薬価を算定した場合、加算後の薬価であっても欧米主要国の新薬の薬価水準よりも低い傾向があり、外国平均格調整で引下げとなる場合よりも引上げとなる場合が多くなる傾向がある。このように、海外で我が国よりも高い薬価が期待できる医薬品については、海外で先に上市した方が薬価算定に有利であり、国内先行開発に不利な算定方式になっている等の指摘がある。 - 厚生労働省

In relation to social security-related expenditures, the pension system will be reformed to establish a sustainable system harmonious with the society and economy by striking a long-term balance between benefits and burdens and will revise medical service fees and drug prices.例文帳に追加

社会保障関係費については、年金につき、長期的な給付と負担の均衡を図り、社会経済と調和した持続可能な制度への改革に取り組むとともに、診療報酬・薬価等の改定等を行うこととしております。 - 財務省

Regarding social security-related expenditures, we will place priority on measures to ensure the safety and security of people's lives, such as maintaining a sufficient number of doctors in the prefectures where doctors are in demand. At the same time, from the viewpoint of curbing expenditures through continued efforts to reform the social security system, we will implement measures such as revising medical fees and drug prices in a priority-oriented manner, promoting the use of generic drugs and having employee insurance systems provide financial support to the government-managed health care system.例文帳に追加

社会保障関係費については、医師確保対策など国民生活の安全・安心に配慮した重点化を図る一方、社会保障制度の改革努力を継続し歳出の抑制を図る観点から、めり張りのきいた診療報酬・薬価等の改定、後発医薬品の使用促進、被用者保険による政管健保への支援措置等の取組を行っております。 - 財務省

In such situation, citizens’ needs are increasing also for information on pharmaceutical products. It is required to supply easily understandable information on indication, adverse drug reactions and intake method, etc. In addition, by recent increase of medical care expense for citizens, increase of burden on patients and increase of the interest in generics, information supply is also requested on prices and equivalency of original products and generics.例文帳に追加

こうした状況の中で、医薬品情報についても国民のニーズが高まっており、効能・効果、副作用、服用方法等について分かり易い情報の提供が求められているほか、近年の国民医療費の増大や患者負担の増加及び後発医薬品に対する関心の高まりにより、先発医薬品・後発医薬品の価格や同等性についても情報提供が求められている。 - 厚生労働省

Based on the above-described changes in 5 years after establishment of the previous vision and based on the basic direction of promotion of innovation and acceleration of growth potential that are important political tasks in Japan, in order to try strengthening of the international competitive power of the pharmaceutical industry in Japan and resolution of drug lag, thereby aiming wealthy country that can “supply citizens with safe and high-quality pharmaceutical products meeting medical needs as early as possible at reasonable prices”, we decide to establish a new vision for the pharmaceutical industry.例文帳に追加

・ こうした前回ビジョン策定後の 5 年間の変化を踏まえ、また、我が国の重要政策課題であるイノベーションの促進と成長力加速という基本方向を踏まえ、我が国医薬品はじめに産業の国際競争力の強化とドラッグ・ラグの解消を図り、これにより最終的には「医療ニーズに対応した安全で質の高い医薬品が国民にできるだけ速く合理的な価格で提供されること」ができる豊かな国を目指すため、新たな医薬品産業ビジョンを策定することとする。 - 厚生労働省